Collectively, these observations support the notion that inhibition of Chk1 with PRE enhances the anticancer effect of CPX on NSCLC cells by inducing excess DNA damage in NSCLC cells. This evidence concerns the gene CHEK1 and non-small cell lung carcinoma.